Sphere Fluidics is Shortlisted in Genesis BioNewsRound 2014 Award

Posted on

Sphere Fluidics has been shortlisted as a semi-finalist in the Genesis BioNewsRound 2014 Award for its’ press release published on 24th June 2014 entitled “Sphere Fluidics Wins Investment for Development of Unique, Single Cell Analysis Instrument”. This press release was published in both the US and Europe via PRNewsWire, the BioIndustry Association and other press outlets” said Dr Rob Marchmont (Commercial Director). “It had a high hit rate across US and European networks so was an impactful article on Cyto-Mine – the latter is the name for our new single cell analysis instrument”. The semi-final competition occurs in London on 12th November 2014. The original press release is shown here.